Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $17 | $18 | $17 | $13 |
| G&A Expenses | $0 | $5 | $5 | $5 |
| SG&A Expenses | $5 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22 | $23 | $22 | $18 |
| Operating Income | -$23 | -$23 | -$22 | -$18 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $2 | $2 | $9 |
| Pre-Tax Income | -$22 | -$21 | -$20 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22 | -$21 | -$20 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.88 | -0.87 | -0.83 | -0.82 |
| % Growth | -1.1% | -4.8% | -1.2% | – |
| EPS Diluted | -0.88 | -0.87 | -0.83 | -0.82 |
| Weighted Avg Shares Out | 24 | 24 | 24 | 24 |
| Weighted Avg Shares Out Dil | 24 | 24 | 24 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$21 | -$22 | -$22 | -$18 |
| % Margin | – | – | – | – |